|
Worldwide Biotech
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 349 articles |
 Page 1 of 5 
|
INHALER DEVICES STILL A MAJOR HURDLE IN ASTHMA/COPD.
July 01, 2008
SATRAPLATIN SPARC PHASE3 PROSTATE CANCER DATA REPORTED.
July 01, 2008
HEMISPHERX COMPLETES ENROLLMENT IN PHASE II AMPLIGEN STUDY.(Clinical r...
July 01, 2008
ESBATECH'S ANTIBODY FRAGMENT ENTERS CLINICAL DEVELOPMENT.
June 01, 2008
UCB LAUNCHES CIMPLICITY TO ENHANCE TREATMENT SUPPORT FOR CIMZIA.
June 01, 2008
SIMCERE PHARMACEUTICAL AQUIRES 70% STAKE IN WUHU ZONG REN.
June 01, 2008
NVENTA UNVEILS POSITIVE IMMUNOLOGICAL DATA FROM HSPE7 PHASE 1 TRIAL.
May 01, 2008
PAREXEL EXPANDS RELATIONSHIP WITH SYNCHRON IN INDIA.
May 01, 2008
VICAL LICENCEE ANGES MG FILES NDA IN JAPAN FOR COLLATEGENE.
May 01, 2008
BIOTAGE LAUNCHES NEW 24 WELL PYROSEQUENCING SYSTEM.
May 01, 2008
RECEPTOR LOGIC/SANOFI PASTEUR DEVELOP TCR FOR VACCINE TESTS.
April 01, 2008
REACHBIO/AXIOGENESIS TO DISTRIBUTE CELL-BASED PRODUCTS.
April 01, 2008
HUMAN PARTHENOGENETIC STEM CELLS USED FOR NEURAL DISEASES.
April 01, 2008
DEBIOPHARM TO CONTINUE BRAINZ STUDY WITH DEBIO 9902 SR.
April 01, 2008
GENEREX AWARDED PATENTS IN NORTH AND SOUTH AMERICA.
April 01, 2008
HADASSAH/HARVARD MEDICAL BEGIN PHASE 1 FOR AUTOIMMUNE THERAPY.
March 01, 2008
GENEREX GETS APPROVAL FOR ORAL-LYN PHASE III TRIAL.
March 01, 2008
M'S SCIENCE INITIATES EUROPEAN PHASE 2 STROKE RECOVERY.(Medical condit...
March 01, 2008
MYELOMA TREATMENT FOR OLDER PATIENTS SET FOR APPROVAL.
March 01, 2008
PROGEN REPORTS ON PHASE 3 OF PI-88 FOR LIVER CANCER.
February 01, 2008
ABIOMED REPORTS ON EUROPEAN GROWTH STRATEGY.
February 01, 2008
CELL THERAPEUTICS ACQUIRES ZEVLIN FROM BIOGEN IDEC.
February 01, 2008
HEMISPHERX'S CFS CLINICAL PROGRAMS REVIEWED IN EUROPE.
February 01, 2008
QRXPHARMA BEGINS PHASE III CLINICAL TRIAL FOR PAIN THERAPY.
January 01, 2008
MARKETING APPLICATION FOR VORINOSTAT FILED IN EUROPE.
January 01, 2008
OASMIA PHARMACEUTICAL SIGNS LICENSING PACT WITH ORION.
January 01, 2008
FOVEA/GENZYME SIGN OPHTHALMOLOGY RESEARCH PACT.
January 01, 2008
HEALTH CANADA ACCEPTS SANTHERA'S NDS FOR SNT-MC17.
January 01, 2008
UCB INITIATES PHASE III RIKRLTS TRIAL FOR EPILEPSY.
December 01, 2007
BIOLINERX REPORTS POSITIVE RESULTS FROM BL-1020 TRIAL.(Clinical report...
December 01, 2007
SNT-MC17 PHASE IIA FOR MUSCULAR DYSTROPHY ENCOURAGING.(Clinical report...
December 01, 2007
SURVIVAL ANALYSIS FROM SATRAPLATIN TRIAL DISAPPOINTING.
December 01, 2007
PHASE III TRIAL TO EVALUATE NEUROAID IN STROKE RECOVERY.(Clinical repo...
November 01, 2007
OREXO'S RAPINYL NEARING REGULATORY DECISION IN EUROPE.
November 01, 2007
MEDICINOVA REPORTS POSITIVE RESULTS FOR PHASE I OF MN-029.
November 01, 2007
CHINESE SFDA GRANTS IMMTECH FAST TRACK STATUS.
November 01, 2007
INNEXUS UNVEILS DXL625 ANTI-CD20 MONOCLONAL ANTIBODY.
October 01, 2007
CLINICAL DATA ACQUIRES EPIDAUROS BIOTECHNOLOGIE AG.
October 01, 2007
BIOLINERX IN-LICENSES NOVEL DRUG FOR ACUTE KIDNEY INJURY.
October 01, 2007
MED DISCOVERY/DRAXIMAGE SIGN COLLABORATION PACT.
October 01, 2007
BIOLINERX/UNIVERSITY OF ILLINOIS TO DEVELOP APOPTOSIS AGENT.
September 01, 2007
STARPHARMA REPORTS POSITIVE RESULTS WITH VIVAGEL.(Financial report)
September 01, 2007
TIKVAH LICENSES ACADEMIA SINICA NEURODEGENERATIVE PATENTS.
September 01, 2007
BIOLINERX STARTS PHASE II TRIAL OF BL-1020 FOR SCHIZOPHRENIA.
September 01, 2007
ROSETTA/WEIZMAN INSTITUTE IDENTIFY ROLE OF MICRORNA.
August 01, 2007
CHELSEA THERAPEUTICS INITIATES CH-150 BIOEQUIVALENCE STUDY.
August 01, 2007
HEMISPHERX INITIATES AMPLIGEN PHASE IIB FOR INFLUENZA.
August 01, 2007
S*BIO INITIATES CLINICAL TRIAL OF NOVEL ANTI-CANCER DRUG.
August 01, 2007
SHIRE SIGNS DEAL WITH SAMARITAN TO LAUNCH REPAGAL FOR FABRY.
July 01, 2007
DRAXIS GETS ACCEPTABLITY AFTER INSPECTON OF MANUFACTURING.
July 01, 2007
MIRCERA GETS POSITIVE OPINION IN EUROPE FOR ANAEMIA.
July 01, 2007
S*BIO/UNIVERSITY OF SINGAPORE PARTNER ON TUMOR BIOAMARKER.
July 01, 2007
ONCOLYTICS BIOTECH GETS 21ST U.S. PATENT.
July 01, 2007
TOPOTARGET UNVEILS AVUGANE PHASE II TRIAL FOR ACNE VULGARIS.(Clinical ...
June 01, 2007
NEUROMED LICENSES PHASE 3 CHRONIC PAIN PRODUCT FROM ALZA.
June 01, 2007
CHMP ADOPTS POSITIVE OPINION FOR ALEXION'S SOLIRIS IN EUROPE.
June 01, 2007
ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE.
June 01, 2007
BIOLINERX LICENSES PEPTIDE FOR INFLAMMATORY DISEASES.
May 01, 2007
FIRST HEART ATTACK PATIENT ENROLLED IN RAPID MI-ICE STUDY.
May 01, 2007
UCB INITIATES ADDITIONAL SHORT-TERM CLINICAL STUDY OF CIMZIA.
May 01, 2007
SATRAPLATIN REDUCES RISK OF PROSTATE CANCER PROGRESSION.
April 01, 2007
SLOAN CANCER VACCINE PHASE III STUDY BEGINS.
April 01, 2007
GREEK MINISTRY APPROVES PRICE INCREASE FOR AMPHOCIL.
April 01, 2007
ARCHIMEDES PHARMA BEGINS PHASE III FOR NASALFENT.
March 01, 2007
FDA CLEARS BIOMS MEDICAL FOR PHASE III MULTIPLE SCLEROSIS.
March 01, 2007
RUSSIAN MEDICAL ADVANCES SHOW UNPRECEDENTED ANTI-AGING.
March 01, 2007
EVOGENIX GRANTED US PATENT.
March 01, 2007
LIPOXEN SIGNS $75MIL PACT TO DEVELOP BLOOD CLOTTING FACTORS.
February 01, 2007
UCB GETS POSITIVE RESULTS FROM TWO CIMIZIA PHASE III STUDIES.
February 01, 2007
APPROVAL FOR U.K. CLINICAL TRIAL FOR REOLYSIN.
February 01, 2007
DIGILAB'S PREP SERVICES USED FOR DIABETES RESEARCH.
February 01, 2007
ANECOVA UNVEILS NEW APPROACH FOR ASSISTED REPRODUCTION.
February 01, 2007
SEMBIOSYS SIGNS PACT FOR CANGENE PLANT-PRODUCED INSULIN.
January 01, 2007
US FAST-TRACKS PHARMAXIS CYSTIC FIBROSIS DRUG.
January 01, 2007
DESPITE BENEFITS, GENE EXPRESSION FACES HURDLES.
January 01, 2007
|
1